查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594435

無針給藥市場：按技術、按應用分類 - 2025-2030 年全球預測

Needle Free Drug Delivery Device Market by Technology (Inhaler Technology, Jet Injectors, Novel Needle-Free Technologies), Application (Insulin Delivery for Diabetes, Pain Management, Pediatric Injections) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年無針給藥市值為118.9億美元，預計2024年將達137億美元，複合年成長率為15.27%，預計到2030年將達到321.7億美元。

無針給藥裝置代表了醫療技術的革命性進步，旨在消除傳統針頭注射帶來的不適和焦慮。這些設備廣泛應用於胰島素給藥、疫苗給藥、疼痛管理、荷爾蒙給藥等。對以患者為中心的醫療保健解決方案的需求不斷成長、合規性的提高以及需要持續治療管理的慢性病的患病率不斷增加，推動了對此類創新的需求。從最終用途的角度來看，主要相關人員包括醫院、診所、家庭護理機構和尋求有效藥物輸送替代方案的製藥公司。市場成長受到技術進步、醫療保健支出增加以及轉向對患者更友善的給藥系統的顯著影響。值得注意的是，不斷成長的老年人口以及對針刺傷害相關風險的認知也在推動市場向前發展方面發揮關鍵作用。然而，高昂的初始成本、技術限制和監管障礙等挑戰可能會阻礙市場擴張。機會在於不斷開發易於使用且具有成本效益且具有精確劑量功能的設備。透過整合整合物聯網功能等數位健康技術，公司可以進行創新，以監控患者的用藥依從性和治療效果。另一個有前景的領域是研究和開發生物分解性和生物相容性材料，以使設備更具永續和可接受性。對公司的建議包括投資於強力的研究和開發計劃，與醫療保健提供者和付款人建立策略合作夥伴關係，以及全面的消費者教育計劃以提高採用率。儘管市場競爭激烈且對監管變化敏感，但利用新技術並解決消費者擔憂的公司可以獲得顯著的競爭優勢。總體而言，在患者對非侵入性治療選擇和技術創新的需求的推動下，無針給藥設備市場將出現動態成長。

主要市場統計
基準年[2023] 118.9億美元
預測年份 [2024] 137億美元
預測年份 [2030] 321.7億美元
複合年成長率（%） 15.27%

市場動態：揭示快速發展的無針給藥市場的關鍵市場洞察

無針給藥市場正因供給與需求的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 自行將高黏度藥物注入體內的需求不斷增加
    • 世界性糖尿病等慢性疾病的增加
    • 人們對控制肝炎和愛滋病等感染疾病傳播的興趣日益濃厚
  • 市場限制因素
    • 與傳統噴射系統相比，開發成本較高
  • 市場機會
    • 無痛給藥領域技術快速進步
    • 介紹技術先進的產品，如胰島素筆、胰島素幫浦和其他設備
  • 市場挑戰
    • 提供替代藥物傳輸模式和所需的無菌系統維護

波特五力：駕馭無針給藥市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對無針給藥市場的影響

外部宏觀環境因素在塑造無針給藥市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解無針給藥市場的競爭格局

對無針給藥市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣無針給藥市場供應商績效評估

FPNV 定位矩陣是評估無針給藥市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了無針給藥市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，無針給藥市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 自行將高黏度藥物注入體內的需求不斷增加
      • 糖尿病等慢性疾病在世界各地不斷增加。
      • 人們越來越關注控制肝炎和愛滋病等感染疾病的傳播。
    • 抑制因素
      • 與傳統噴射系統相比，開發成本較高
    • 機會
      • 無痛藥物轉運領域技術快速進步
      • 胰島素筆、胰島素幫浦等先進科技產品介紹
    • 任務
      • 替代藥物傳遞方法的可用性和所需的無菌系統的維護
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章無針給藥市場：依技術分類

  • 吸入器技術
  • 噴射注射器
  • 新型無針技術
  • 口服給藥系統
  • 經皮吸收貼片技術

第7章 無針給藥市場：依應用分類

  • 糖尿病的胰島素給藥
  • 疼痛管理
  • 小兒注射劑
  • 疫苗遞送

第8章美洲無針給藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區無針給藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲無針給藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • AkraDermojet Inc
  • Antares Pharma Inc.
  • Bayer AG
  • Bioject Medical Technologies, Inc.
  • Crossject
  • Ferring BV
  • GlaxoSmithKline plc
  • Glide Pharmaceutical Technologies Ltd.
  • InjexPharma AG
  • MannKind Corporation
  • Medtronic, Inc.
  • Mika Medical Co.
  • PenJet
  • Zogenix, Inc.
Product Code: MRR-036C5CF3B48C

The Needle Free Drug Delivery Device Market was valued at USD 11.89 billion in 2023, expected to reach USD 13.70 billion in 2024, and is projected to grow at a CAGR of 15.27%, to USD 32.17 billion by 2030.

Needle-free drug delivery devices represent a revolutionary advance in medical technology, aiming to eliminate the discomfort and anxiety often associated with traditional needle-based injections. These devices have found widespread application in insulin administration, vaccine delivery, pain management, and hormone delivery. The necessity for such innovations is driven by the growing demand for patient-centric healthcare solutions, improved compliance, and the increasing prevalence of chronic diseases requiring ongoing therapeutic management. In terms of end-use, key stakeholders include hospitals, clinics, home-care settings, and pharmaceutical companies looking for effective drug delivery alternatives. Market growth is being significantly influenced by technological advancements, rising healthcare expenditure, and a shift towards more patient-friendly drug delivery systems. Notably, the increasing geriatric population and awareness about the risks associated with needle-stick injuries also play significant roles in propelling the market forward. However, challenges such as high initial costs, technical limitations, and regulatory hurdles can hinder market expansion. Opportunities lie in the continuous development of easy-to-use, cost-effective devices equipped with precise dosing capabilities. Companies can innovate by incorporating digital health technologies, such as integrated IoT features, to monitor patient adherence and treatment effectiveness. Another promising area is the research and development of biodegradable and biocompatible materials to make the devices more sustainable and acceptable. Recommendations for businesses include investment in robust R&D initiatives, strategic collaborations with healthcare providers and payers, and comprehensive consumer education programs to increase adoption rates. While the market is competitive and sensitive to regulatory changes, companies that leverage emerging technologies and address prevailing consumer concerns stand to gain a substantial competitive edge. Overall, the needle-free drug delivery device market is poised for dynamic growth fueled by patient demand for non-invasive treatment options and technological innovations.

KEY MARKET STATISTICS
Base Year [2023] USD 11.89 billion
Estimated Year [2024] USD 13.70 billion
Forecast Year [2030] USD 32.17 billion
CAGR (%) 15.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Needle Free Drug Delivery Device Market

The Needle Free Drug Delivery Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for self-administration of high viscous drug into the body
    • Rising number of chronic diseases such as diabetes globally
    • Growing focus to curb the spread of infectious diseases such as hepatitis and AIDS
  • Market Restraints
    • High development cost compared to conventional injection system
  • Market Opportunities
    • Rapid technological advancement in the field of pain-free drug transportation
    • Introduction of technologically advanced products such as insulin pen, insulin pump, and other devices
  • Market Challenges
    • Availability of alternative modes of drug delivery and requires sterility system maintenance

Porter's Five Forces: A Strategic Tool for Navigating the Needle Free Drug Delivery Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Needle Free Drug Delivery Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Needle Free Drug Delivery Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Needle Free Drug Delivery Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Needle Free Drug Delivery Device Market

A detailed market share analysis in the Needle Free Drug Delivery Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Needle Free Drug Delivery Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Needle Free Drug Delivery Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Needle Free Drug Delivery Device Market

A strategic analysis of the Needle Free Drug Delivery Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Needle Free Drug Delivery Device Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AkraDermojet Inc, Antares Pharma Inc., Bayer AG, Bioject Medical Technologies, Inc., Crossject, Ferring B.V., GlaxoSmithKline plc, Glide Pharmaceutical Technologies Ltd., InjexPharma AG, MannKind Corporation, Medtronic, Inc., Mika Medical Co., PenJet, and Zogenix, Inc..

Market Segmentation & Coverage

This research report categorizes the Needle Free Drug Delivery Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Inhaler Technology, Jet Injectors, Novel Needle-Free Technologies, Oral Drug Delivery System, and Transdermal Patch Technology.
  • Based on Application, market is studied across Insulin Delivery for Diabetes, Pain Management, Pediatric Injections, and Vaccine Delivery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for self-administration of high viscous drug into the body
      • 5.1.1.2. Rising number of chronic diseases such as diabetes globally
      • 5.1.1.3. Growing focus to curb the spread of infectious diseases such as hepatitis and AIDS
    • 5.1.2. Restraints
      • 5.1.2.1. High development cost compared to conventional injection system
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid technological advancement in the field of pain-free drug transportation
      • 5.1.3.2. Introduction of technologically advanced products such as insulin pen, insulin pump, and other devices
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative modes of drug delivery and requires sterility system maintenance
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Needle Free Drug Delivery Device Market, by Technology

  • 6.1. Introduction
  • 6.2. Inhaler Technology
  • 6.3. Jet Injectors
  • 6.4. Novel Needle-Free Technologies
  • 6.5. Oral Drug Delivery System
  • 6.6. Transdermal Patch Technology

7. Needle Free Drug Delivery Device Market, by Application

  • 7.1. Introduction
  • 7.2. Insulin Delivery for Diabetes
  • 7.3. Pain Management
  • 7.4. Pediatric Injections
  • 7.5. Vaccine Delivery

8. Americas Needle Free Drug Delivery Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Needle Free Drug Delivery Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Needle Free Drug Delivery Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. AkraDermojet Inc
  • 3. Antares Pharma Inc.
  • 4. Bayer AG
  • 5. Bioject Medical Technologies, Inc.
  • 6. Crossject
  • 7. Ferring B.V.
  • 8. GlaxoSmithKline plc
  • 9. Glide Pharmaceutical Technologies Ltd.
  • 10. InjexPharma AG
  • 11. MannKind Corporation
  • 12. Medtronic, Inc.
  • 13. Mika Medical Co.
  • 14. PenJet
  • 15. Zogenix, Inc.

LIST OF FIGURES

  • FIGURE 1. NEEDLE FREE DRUG DELIVERY DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEEDLE FREE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEEDLE FREE DRUG DELIVERY DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INHALER TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY NOVEL NEEDLE-FREE TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ORAL DRUG DELIVERY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TRANSDERMAL PATCH TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN DELIVERY FOR DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PEDIATRIC INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINE DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. NEEDLE FREE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023